Antidepressants versus placebo for panic disorder in adults. (Q52604885)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

meta-analysis

0 references

title

Antidepressants versus placebo for panic disorder in adults (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Toshi A Furukawa

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

author name string

Irene Bighelli

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Mariasole Castellazzi

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Francesca Girlanda

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Giuseppe Guaiana

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Markus Koesters

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Giulia Turrini

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

Corrado Barbui

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

publication date

5 April 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

22 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

volume

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

page(s)

CD010676

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

Superiority of clomipramine over imipramine in the treatment of panic disorder: a placebo-controlled trial

22 March 2020

cites work

1 reference

12 December 2020

Drug treatment of panic disorder. Comparative efficacy of alprazolam, imipramine, and placebo. Cross-National Collaborative Panic Study, Second Phase Investigators

1 reference

12 December 2020

Imipramine-lnduced Jitteriness and Decreased Serum Iron Levels

1 reference

12 December 2020

The Galway Study of Panic Disorder. I: Clomipramine and lofepramine in DSM III-R panic disorder: a placebo controlled trial

1 reference

12 December 2020

[Treatment of autonomic crises (attacks of panic)]

1 reference

12 December 2020

Serotonin function in panic disorder: a double blind placebo controlled study with fluvoxamine and ritanserin

1 reference

12 December 2020

The sequence of improvement of the symptoms encountered in patients with panic disorder

1 reference

12 December 2020

Avoidance behaviour: a predictor of the efficacy of pharmacotherapy in panic disorder?

1 reference

12 December 2020

Chronology of panic and avoidance, age of onset in panic disorder, and prediction of treatment response. A report from the Cross-National Collaborative Panic Study

1 reference

12 December 2020

Efficacy and safety of alprazolam, imipramine and placebo in treating panic disorder. A Scandinavian multicenter study

1 reference

12 December 2020

Characteristics of panic disorder patients responding to placebo

1 reference

12 December 2020

Alprazolam, imipramine and placebo treatment of panic disorder: predicting therapeutic response

1 reference

12 December 2020

Surreptitious drug use by patients in a panic disorder study

1 reference

12 December 2020

Depression and panic anxiety: the effect of depressive co-morbidity on response to drug treatment of patients with panic disorder and agoraphobia

1 reference

12 December 2020

How "blind" are double-blind studies?

1 reference

12 December 2020

Patients with panic disorder unaccompanied by depression improve with alprazolam and imipramine treatment

1 reference

12 December 2020

The sequence of improvement of the symptoms encountered in patients with panic disorder

1 reference

12 December 2020

[Comparison of the effect of alprazolam, imipramine and placebo in the treatment of panic disorders in Cali, Colombia]

1 reference

12 December 2020

Self- and observer assessment in anxiolytic drug trials: a comparison of their validity

1 reference

12 December 2020

Consistencies and discrepancies in self- and observer-rated anxiety scales. A comparison between the self- and observer-rated Marks-Sheehan scales

1 reference

12 December 2020

Cardiovascular and symptomatic reduction effects of alprazolam and imipramine in patients with panic disorder: results of a double-blind, placebo-controlled trial

1 reference

12 December 2020

Drug treatment of panic disorder: early response to treatment as a predictor of final outcome

1 reference

12 December 2020

Is buspirone effective for panic disorder?

1 reference

12 December 2020

Selective monoamine uptake inhibitors and a serotonin antagonist in the treatment of panic disorder

1 reference

12 December 2020

Response of panic disorder to fixed doses of alprazolam or imipramine

1 reference

12 December 2020

Imipramine dose-response relationship in panic disorder with agoraphobia. Preliminary findings

1 reference

12 December 2020

Serotonergic anxiolytics in the treatment of panic disorder: a controlled study with buspirone

1 reference

12 December 2020

Effect of a selective serotonin uptake inhibitor in agoraphobia with panic attacks. A double-blind comparison of zimeldine, imipramine and placebo

1 reference

12 December 2020

Effect of a serotonin precursor and uptake inhibitor in anxiety disorders; a double-blind comparison of 5-hydroxytryptophan, clomipramine and placebo

1 reference

12 December 2020

The design and conduct of the Upjohn Cross-National Collaborative Panic Study

1 reference

12 December 2020

Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo

1 reference

12 December 2020

Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study

1 reference

12 December 2020

DSM-IV and the disappearance of agoraphobia without a history of panic disorder: new data on a controversial diagnosis

1 reference

12 December 2020

Clomipramine treatment and behaviour therapy with agoraphobic women

1 reference

12 December 2020

MAO inhibitors in panic disorder: clinical effects of treatment with brofaromine. A double blind placebo controlled study

1 reference

12 December 2020

Panic and panic disorder in the United States

1 reference

12 December 2020

Maintenance drug therapy of panic disorder

1 reference

12 December 2020

Blood pressure and heart rate response of panic disorder patients receiving imipramine in a dose-response treatment paradigm

1 reference

12 December 2020

Adverse effects associated with the short-term treatment of panic disorder with imipramine, alprazolam or placebo

1 reference

12 December 2020

Neurobiological mechanisms involved in antidepressant therapies

1 reference

12 December 2020

Effect of fluvoxamine on panic disorder

1 reference

12 December 2020

Clomipramine in the treatment of agoraphobic inpatients resistant to behavioral therapy

1 reference

12 December 2020

Preliminary report: placebo-controlled, double-blind study of the clinical and metabolic effects of desipramine in panic disorder

1 reference

12 December 2020

Influence of depression on the treatment of panic disorder with imipramine, alprazolam and placebo

1 reference

12 December 2020

A Comparison of Fluvoxamine, Cognitive Therapy, and Placebo in the Treatment of Panic Disorder

1 reference

12 December 2020

Maintenance drug treatment of panic disorder. I. Results of a prospective, placebo-controlled comparison of alprazolam and imipramine

1 reference

12 December 2020

Maintenance drug treatment for panic disorder. II. Short- and long-term outcome after drug taper

1 reference

12 December 2020

Changes in appetite and weight during the pharmacological treatment of patients with panic disorder

1 reference

12 December 2020

A multiple imputation strategy for clinical trials with truncation of patient data

1 reference

12 December 2020

Minnesota Multiphasic Personality Inventory correlates of panic disorder with agoraphobia: changes with treatment

1 reference

12 December 2020

Long-term follow-up after a drug trial for panic disorder

1 reference

12 December 2020

Detecting skewness from summary information

1 reference

12 December 2020

A double-blind placebo-controlled trial comparing fluvoxamine and imipramine in the treatment of panic disorder with or without agoraphobia

1 reference

12 December 2020

A comparison of paroxetine, clomipramine and placebo in the treatment of panic disorder. Collaborative Paroxetine Panic Study Investigators

1 reference

12 December 2020

Comparison of fluvoxamine, imipramine, and placebo in the treatment of outpatients with panic disorder

1 reference

12 December 2020

Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care

1 reference

12 December 2020

Bias in meta-analysis detected by a simple, graphical test

1 reference

12 December 2020

The effect of Citalopram in panic disorder

1 reference

12 December 2020

Double-Blind, Fixed-Dose, Placebo-Controlled Study of Paroxetine in the Treatment of Panic Disorder

1 reference

12 December 2020

Comparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.

1 reference

12 December 2020

Sertraline in the treatment of panic disorder: a double-blind multicenter trial.

1 reference

12 December 2020

A controlled, prospective, 1-year trial of citalopram in the treatment of panic disorder

1 reference

12 December 2020

Sertraline in the treatment of panic disorder: a flexible-dose multicenter trial.

1 reference

12 December 2020

Sertraline in the treatment of panic disorder. A multi-site, double-blind, placebo-controlled, fixed-dose investigation

1 reference

12 December 2020

Prevalence of psychiatric disorder in the general population: results of The Netherlands Mental Health Survey and Incidence Study (NEMESIS).

1 reference

12 December 2020

Panic disorder: long-term pharmacotherapy and discontinuation

1 reference

12 December 2020

Comparative effects of low and high doses of clomipramine and placebo in panic disorder: a double-blind controlled study. French University Antidepressant Group

1 reference

12 December 2020

Treatment of panic disorder in older adults: a pilot study comparison of alprazolam, imipramine, and placebo.

1 reference

12 December 2020

Antidepressants in panic disorder

1 reference

12 December 2020

Paroxetine, Clomipramine, and Cognitive Therapy in the Treatment of Panic Disorder

1 reference

12 December 2020

[The problem of therapeutic efficacy indices. 3. Comparison of the indices and their use]

1 reference

12 December 2020

Citalopram controls phobic symptoms in patients with panic disorder: randomized controlled trial

1 reference

12 December 2020

Neuroanatomical hypothesis of panic disorder, revised

1 reference

12 December 2020

Selective serotonin reuptake inhibitors versus tricyclic antidepressants: a meta-analysis of efficacy and tolerability.

1 reference

12 December 2020

Cognitive-behavioral therapy, imipramine, or their combination for panic disorder: A randomized controlled trial

1 reference

12 December 2020

The Use of the Panic and Agoraphobia Scale (P & A) in a controlled clinical trial1

1 reference

12 December 2020

Fluvoxamine in the treatment of panic disorder: a multi-center, double-blind, placebo-controlled study in outpatients

1 reference

12 December 2020

An effect-size analysis of the relative efficacy and tolerability of serotonin selective reuptake inhibitors for panic disorder.

1 reference

12 December 2020

Emotion-focused psychotherapy for patients with panic disorder

1 reference

12 December 2020

Efficacy of usual antidepressant dosing regimens of fluoxetine in panic disorder: randomised, placebo-controlled trial

1 reference

12 December 2020

Reboxetine, a selective norepinephrine reuptake inhibitor, is an effective and well-tolerated treatment for panic disorder

1 reference

12 December 2020

Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses

1 reference

12 December 2020

Meta-analyses involving cross-over trials: methodological issues

1 reference

12 December 2020

Interactive model of therapeutic response in panic disorder: moclobemide, a case in point

1 reference

12 December 2020

SSRIs vs. TCAs in the treatment of panic disorder: a meta-analysis

1 reference

12 December 2020

The long-term course of panic disorder--an 11 year follow-up

1 reference

12 December 2020

Pharmaceutical industry sponsorship and research outcome and quality: systematic review

1 reference

12 December 2020

Are benzodiazepines still the medication of choice for patients with panic disorder with or without agoraphobia?

1 reference

12 December 2020

Association of funding and conclusions in randomized drug trials: a reflection of treatment effect or adverse events?

1 reference

12 December 2020

Measuring inconsistency in meta-analyses

1 reference

12 December 2020

DELINEATION OF TWO DRUG-RESPONSIVE ANXIETY SYNDROMES

1 reference

12 December 2020

Escitalopram in the treatment of panic disorder: a randomized, double-blind, placebo-controlled trial.

1 reference

12 December 2020

A 15-year follow-up study of patients with panic disorder

1 reference

12 December 2020

Association between industry funding and statistically significant pro-industry findings in medical and surgical randomized trials

1 reference

12 December 2020

Industry sponsorship and authorship of clinical trials over 20 years

1 reference

12 December 2020

Grading quality of evidence and strength of recommendations

1 reference

12 December 2020

Imputing response rates from means and standard deviations in meta-analyses

1 reference

12 December 2020

Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.

1 reference

12 December 2020

A placebo-controlled, randomized withdrawal study of sertraline for panic disorder in Japan

1 reference

12 December 2020

Metabotropic glutamate II receptor agonists in panic disorder: a double blind clinical trial with LY354740.

1 reference

12 December 2020

Venlafaxine extended-release capsules in panic disorder: flexible-dose, double-blind, placebo-controlled study

1 reference

12 December 2020

Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology

1 reference

12 December 2020

Imputing missing standard deviations in meta-analyses can provide accurate results

1 reference

12 December 2020

The epidemiology of panic attacks, panic disorder, and agoraphobia in the National Comorbidity Survey Replication

1 reference

12 December 2020

The epidemiology of DSM-IV panic disorder and agoraphobia in the United States: results from the National Epidemiologic Survey on Alcohol and Related Conditions

1 reference

12 December 2020

Single data extraction generated more errors than double data extraction in systematic reviews

1 reference

12 December 2020

A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder

1 reference

12 December 2020

What is the threshold for symptomatic response and remission for major depressive disorder, panic disorder, social anxiety disorder, and generalized anxiety disorder?

1 reference

12 December 2020

Combined psychotherapy plus antidepressants for panic disorder with or without agoraphobia

1 reference

12 December 2020

A comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy

1 reference

12 December 2020

Which panic disorder patients benefit from which treatment: cognitive therapy or antidepressants?

1 reference

12 December 2020

A randomized controlled trial of venlafaxine ER and paroxetine in the treatment of outpatients with panic disorder.

1 reference

12 December 2020

Arcsine test for publication bias in meta-analyses with binary outcomes.

1 reference

12 December 2020

Improvement of Quality of Life in Panic Disorder with Escitalopram, Citalopram, or Placebo

1 reference

12 December 2020

Prevalence of common mental disorders in general practice attendees across Europe

1 reference

12 December 2020

Serotonin 5-HT1A receptor binding in people with panic disorder: positron emission tomography study

1 reference

12 December 2020

Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale.

1 reference

12 December 2020

A double-blind, placebo-controlled, parallel-group, flexible-dose study of venlafaxine extended release capsules in adult outpatients with panic disorder

1 reference

12 December 2020

Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement

1 reference

12 December 2020

Psychological treatment of panic disorder with or without agoraphobia: a meta-analysis

1 reference

12 December 2020

CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials

1 reference

12 December 2020

A randomized trial of sertraline, self-administered cognitive behavior therapy, and their combination for panic disorder

1 reference

12 December 2020

Pharmacologic treatment of panic disorder.

1 reference

12 December 2020

Clomipramine, a better reference drug for panic/agoraphobia. I. Effectiveness comparison with imipramine

1 reference

12 December 2020

Clomipramine, a better reference drug for panic/agoraphobia. II. Psychomotor and cognitive effects.

1 reference

12 December 2020

Newer antidepressants and panic disorder: a meta-analysis

1 reference

12 December 2020

Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis

1 reference

12 December 2020

Antidepressants and benzodiazepines for panic disorder in adults.

1 reference

12 December 2020

Rayyan-a web and mobile app for systematic reviews.

1 reference

12 December 2020

10.1002/14651858.CD010676.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29620793 AND SRC:MED&resulttype=core&format=json

22 March 2020

PubMed publication ID

29620793

1 reference